• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于环介导等温扩增的新型基因分型方法及其在家族性高胆固醇血症中鉴定前蛋白转化酶枯草溶菌素/克胰蛋白酶 9 变异体中的应用。

A novel loop-mediated isothermal amplification-based genotyping method and its application for identifying proprotein convertase subtilisin/kexin type 9 variants in familial hypercholesterolemia.

机构信息

Division of Community and Family Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-City, Tochigi 329-0498, Japan; Eiken Chemical Co., Ltd., 143 Nogi, Nogi-Town, Shimotsuga, Tochigi 329-0114, Japan.

Eiken Chemical Co., Ltd., 143 Nogi, Nogi-Town, Shimotsuga, Tochigi 329-0114, Japan.

出版信息

Biochim Biophys Acta Gen Subj. 2022 Feb;1866(2):130063. doi: 10.1016/j.bbagen.2021.130063. Epub 2021 Nov 27.

DOI:10.1016/j.bbagen.2021.130063
PMID:34848321
Abstract

BACKGROUND

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in regulating low-density lipoprotein levels in plasma. While PCSK9 variants are causatively associated with familial hypercholesterolemia (FH), additional genotyping methods for FH targeting PCSK9 variants are required in a clinical setting. Loop-mediated isothermal amplification (LAMP) is a unique amplification method that amplifies a target gene under isothermal conditions (60-65 °C). However, a robust standardized method has not yet been established for LAMP-based genetic screening tests for genetic diseases, including FH. The present study aimed to develop a novel modification of the LAMP method designed to genotype single nucleotide variants (SNVs) and to apply it for the detection of PCSK9 variants.

METHODS

Using short quenching probes (≤ 10 nucleotides) for the loop structures of LAMP amplicons, accurate detection of SNVs was verified separately for each allele, without any additional procedures, within 3 h. The diagnostic performance of this method in detecting PCSK9 variants was validated in FH patients.

RESULTS

All PCSK9 variants tested via conventional sequencing in FH patients were successfully detected using this novel LAMP method.

CONCLUSIONS

We developed a LAMP-based genotyping method to detect PCSK9 variants in FH. Compared to conventional sequencing, our genotyping method is relatively convenient and time-efficient and is suitable for the screening of FH in clinical settings. Future studies on various genes are also warranted.

摘要

背景

前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9(PCSK9)在调节血浆中低密度脂蛋白水平方面发挥着关键作用。虽然 PCSK9 变体与家族性高胆固醇血症(FH)密切相关,但在临床环境中还需要针对 PCSK9 变体的 FH 额外基因分型方法。环介导等温扩增(LAMP)是一种独特的扩增方法,可在等温条件(60-65°C)下扩增靶基因。然而,针对包括 FH 在内的遗传疾病的基于 LAMP 的遗传筛选测试尚未建立稳健的标准化方法。本研究旨在开发一种新的 LAMP 方法修饰,用于对单核苷酸变异(SNVs)进行基因分型,并将其应用于 PCSK9 变体的检测。

方法

使用 LAMP 扩增子环结构的短淬灭探针(≤10 个核苷酸),分别针对每个等位基因,在 3 小时内无需任何额外程序即可验证 SNVs 的准确检测。该方法在 FH 患者中检测 PCSK9 变体的诊断性能通过验证进行了验证。

结果

通过对 FH 患者进行常规测序检测到的所有 PCSK9 变体均成功地使用这种新型 LAMP 方法检测到。

结论

我们开发了一种基于 LAMP 的基因分型方法,用于检测 FH 中的 PCSK9 变体。与传统测序相比,我们的基因分型方法相对方便且高效,适用于临床环境中的 FH 筛查。未来还需要对各种基因进行研究。

相似文献

1
A novel loop-mediated isothermal amplification-based genotyping method and its application for identifying proprotein convertase subtilisin/kexin type 9 variants in familial hypercholesterolemia.一种基于环介导等温扩增的新型基因分型方法及其在家族性高胆固醇血症中鉴定前蛋白转化酶枯草溶菌素/克胰蛋白酶 9 变异体中的应用。
Biochim Biophys Acta Gen Subj. 2022 Feb;1866(2):130063. doi: 10.1016/j.bbagen.2021.130063. Epub 2021 Nov 27.
2
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.开普敦家族性高胆固醇血症患者中的新型 PCSK9(前蛋白转化酶枯草溶菌素 9)变异体。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):934-943. doi: 10.1161/ATVBAHA.120.314482. Epub 2020 Nov 5.
3
Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.具有低密度脂蛋白受体(LDLR)突变的前蛋白转化酶枯草杆菌蛋白酶/kexin 9 V4I变体改变家族性高胆固醇血症的表型。
J Clin Lipidol. 2016 May-Jun;10(3):547-555.e5. doi: 10.1016/j.jacl.2015.12.024. Epub 2016 Jan 6.
4
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.由前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)功能获得性突变引起的纯合子家族性高胆固醇血症的基因型和表型特征。
Atherosclerosis. 2014 Sep;236(1):54-61. doi: 10.1016/j.atherosclerosis.2014.06.005. Epub 2014 Jun 26.
5
Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.载脂蛋白 B 代谢途径相关基因致病性变异在日本杂合子家族性高胆固醇血症患者中的影响。
Atherosclerosis. 2019 Oct;289:101-108. doi: 10.1016/j.atherosclerosis.2019.08.004. Epub 2019 Aug 19.
6
LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy.家族性高胆固醇血症患者的 LDL-胆固醇和 PCSK9:降脂治疗下 PCSK9 变异体的影响。
J Clin Lab Anal. 2021 Nov;35(11):e24056. doi: 10.1002/jcla.24056. Epub 2021 Oct 15.
7
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.家族性高胆固醇血症患者的前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 血清水平表明,前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 通过 LDL 受体非依赖途径从血浆中清除。
Transl Res. 2012 Aug;160(2):125-30. doi: 10.1016/j.trsl.2012.01.010. Epub 2012 Jan 31.
8
Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.载脂蛋白 B、前蛋白转化酶枯草溶菌素 9 及其他与马来西亚家族性高胆固醇血症相关的脂质相关基因中的 LDLR 遗传多态性。
PLoS One. 2013 Apr 8;8(4):e60729. doi: 10.1371/journal.pone.0060729. Print 2013.
9
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.血浆诱导 LDLR、可溶性低密度脂蛋白受体和前蛋白转化酶枯草溶菌素/糜蛋白酶 9 水平降低可作为儿童家族性高胆固醇血症潜在的生物标志物。
J Clin Lipidol. 2018 Jan-Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.
10
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.载脂蛋白(a)表型决定了潜在家族性高胆固醇血症患者脂蛋白(a)和前蛋白转化酶枯草溶菌素/克那霉 9 水平的相关性。
Atherosclerosis. 2018 Oct;277:477-482. doi: 10.1016/j.atherosclerosis.2018.08.011.